January ****
Kevin L. Wallace, MD, FACMT
Contact Information
Forensic MedTox, LLC Website: www.forensicmedtox.com
P.O. Box 50982 Email: acchyz@r.postjobfree.com
Sarasota, FL 34232-0308 Tel: 207-***-****
Summary Profile
Dr. Wallace is Founder and Director of Forensic MedTox, LLC, as established in June of 2013 and posted
on the website cited above. For more than 15 years, he has provided forensic medical toxicology
consultant and expert witness service, based on his education, experience, training, board certification,
and professional experience, and has held clinical and academic positions in numerous geographic and
professional settings.
Employment
2013-present Forensic MedTox, LLC South Portland, Maine
Founder/Director/Forensic Expert Witness/Consultant
2004-present Veritox, Inc. Redmond, Washington
Part-time Director of Medical Toxicology
2010-2012 University of New England College of Pharmacy Portland, Maine
Full-time Faculty Member, Department of Pharmacy Practice
1997-2010 Banner Good Samaritan Medical Center Phoenix, Arizona
Phoenix Children’s Hospital (1997-2008)
Attending Physician, Department of Medical Toxicology;
Director, Occupational & Environmental Toxicology Services;
Associate Director, Banner Poison Center
2008-2009 University of Virginia Health System Charlottesville, Virginia
Attending Physician, Department of Emergency Medicine,
Division of Medical Toxicology
2003-2008 Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire
Attending Physician, Department of Medicine: Division of Clinical
Pharmacology and Toxicology; Division of Occupational and
Environmental Medicine
2004-2006 Center for Environmental Health Sciences at Dartmouth Hanover, New Hampshire
Associate Director
2003-2004 Maricopa Medical Center Phoenix, Arizona
Courtesy Staff Physician, Department of Emergency Medicine
2002-2004 New Hampshire Poison Information Center Lebanon, New Hampshire
Medical Director
Kevin L. Wallace, MD, FACMT
1999-2004 City of Phoenix Fire Department Phoenix, Arizona
Medical Review Officer
1993-1995 Maine Poison Center Portland, Maine
Medical Director
1988-1995 Maine Medical Center Portland, Maine
Attending Physician, Emergency Department
1987-1988 Crawford W. Long Hospital Atlanta, Georgia
Attending Physician, Emergency Department
1984-1985 Southside Community Hospital Farmville, Virginia
Staff Physician, Emergency Department
1977-1979 Harvard Medical School/Robert B. Brigham Hospital Boston, Massachusetts
Research Assistant
Professional Licensure/Board Certification
Florida Department of Health – Medical Doctor Expert Witness
2013-present
1999-present American Board of Emergency Medicine - Medical Toxicology
1988-present Maine Board of Licensure in Medicine
1984-present Commonwealth of Virginia Board of Medicine
1995-2010 Arizona Medical Board
1998-2009 Medical Review Officer Certification Council (MROCC)
2002-2008 New Hampshire Board of Medicine
ABEM – Emergency Medicine
1988-2007
1985-1988 State of Georgia Board of Medicine
Education/Training
2011 University of New England Portland, Maine
Graduate studies: Environmental Health Science
2007-2008 University of Southern Maine Portland, Maine
Graduate studies: Health Care Management; Epidemiological Research
1999 Arizona State University Tempe, Arizona
Graduate studies: Clinical Epidemiology & Biostatistics
2
Kevin L. Wallace, MD, FACMT
1995-1997 Good Samaritan Regional Medical Center Phoenix, Arizona
Medical Toxicology Fellowship
1985-1987 Emory University/Grady Memorial Hospital Atlanta, Georgia
Emergency Medicine Residency
1983-1984 University of Virginia/Roanoke Memorial Hospitals Roanoke, Virginia
Medical Internship
1979-1983 University of Virginia School of Medicine Charlottesville, Virginia
Medical Degree
1972-1976 Amherst College Amherst, Massachusetts
Bachelor of Arts
Academic Appointments
2010-2012 University of New England College of Pharmacy Portland, Maine
Associate Professor, Department of Pharmacy Practice
1999-2010 University of Arizona College of Medicine Tucson, Arizona
Clinical Associate Professor, Department of Emergency Medicine,
Division of Medical Toxicology
2008-2009 University of Virginia School of Medicine Charlottesville, Virginia
Adjunct Clinical Faculty, Department of Emergency Medicine,
Division of Medical Toxicology
2006-2008 University of Massachusetts Medical School Worcester, Massachusetts
Adjunct Clinical Faculty, Department of Emergency Medicine,
Division of Medical Toxicology
2004-2008 Dartmouth Medical School Hanover, New Hampshire
Clinical Adjunct Associate Professor of Medicine,
Division of Pharmacology and Toxicology
1989-1995 University of Vermont School of Medicine Burlington, Vermont
Clinical Assistant Professor, Department of Surgery
1987-1988 Emory University School of Medicine Atlanta, Georgia
Clinical Assistant Professor, Department of Preventive Medicine,
Division of Emergency Medicine
Professional Association Membership
1995-present American College of Medical Toxicology
1993-2012 American Academy of Clinical Toxicology
3
Kevin L. Wallace, MD, FACMT
2005-2008 American College of Occupational and Environmental Medicine
1997-2008 Association of Occupational and Environmental Clinics
1985-2002 American College of Emergency Physicians
1991-1995 Society of Academic Emergency Medicine
1988-1992 National Association of EMS Physicians
Professional Honors and Awards
“Highly Commended”, British Medical Association Book Competition
2005
2002 Fellow, American College of Medical Toxicology
2000 Micromedex Best Scientific Abstract, North American Congress of Clinical
Toxicology
1999 Fellow, American College of Emergency Physicians
1987 Chief Resident in Emergency Medicine, Emory University
Professional and Community Outreach
Committee/Work Group Activities
2011-present Member, ACMT Education Committee
2011-present Member, ACMT Medication Management Section
2012-2013 Board Member, Maine Division of New England Rural Health Round Table
2012-2013 Board Member, H.O.P.E. Group
2009-2013 Member, State of Maine Academic Detailing Advisory Committee
2011-2012 Member, Occupational Medicine Tox Task Forum
2009 Member, Inhalation Toxicology Advisory Group, Virginia Dept. of Environ. Quality
2007-2008 Member, ACMT Liaison Committee
2006-2009 Reviewer, North American Congress of Clinical Toxicology Abstract Committee
2006-2010 Member, ACMT Practice Committee
2007 Reviewer, ATSDR/ACMT Chemical Agents of Opportunity Course
4
Kevin L. Wallace, MD, FACMT
2006 Reviewer, Immunotoxicology, Toxicology Principles for the Industrial Hygienist
(AIHA)
2006 Reviewer, NIH/NINDS CounterACT grant program
2006 Reviewer, ACEP Clinical Policies Subcommittee
2002-2005 Member, State of New Hampshire Public Health Laboratories, Biomonitoring Council
1999-2001 Member, Pharmacy & Therapeutics Committee, Banner Good Samaritan Medical
Center
1997-1999 Member, ToxMedic Committee, Bureau of EMS, Arizona Department of Health
Services
1993-1995 Member, Medical Advisory Committee, State of Maine Board of Pesticides Control
1988-1992 Member, Medical Control Board, Southern Maine EMS
Publications
Textbooks
Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology – Diagnosis
and Management of the Critically Poisoned Patient. Philadelphia, PA:Elsevier Mosby. 2005.
Book Chapters
Wallace KL, Kunkel DB. Carbon disulfide. In: Sullivan JB, Krieger GR, eds. Clinical Environmental
Health and Toxic Exposures, 2nd edition. Philadelphia, PA: Lippincott, Williams & Wilkins.
2001:1206-1211.
Wallace KL: Carbon Monoxide. In Ling LJ, Clark RF, Erickson, TB, Trestrail, JH (eds): Toxicology
Secrets. Philadelphia, PA:Hanley & Belfus. 2001:215-220.
Wallace KL, Morkunas A. Geriatric poisoning. In: Brent J, Wallace KL, Burkhart KK, Phillips SD,
Donovan JW, eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned
Patient. Philadelphia, PA: Elsevier Mosby. 2005:141-147.
Wallace KL. Toxin-induced seizures. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW,
eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned Patient.
Philadelphia, PA: Elsevier Mosby. 2005:225-239.
Tomassoni AJ, Wallace KL. Imidazoline, guanidine, and oxazoline antihypertensives and decongestants.
In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology –
Diagnosis and Management of the Critically Poisoned Patient. Philadelphia, PA: Elsevier Mosby.
2005:441-447.
5
Kevin L. Wallace, MD, FACMT
Wallace KL, Brooks DE. Anxiolytic/sedative-hypnotics. In: Brent J, Wallace KL, Burkhart KK, Phillips
SD, Donovan JW, eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned
Patient. Philadelphia, PA:Elsevier Mosby. 2005:533-546.
Katz KD, Wallace KL. Anti-Parkinson’s medications. In: Brent J, Wallace KL, Burkhart KK, Phillips
SD, Donovan JW, eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned
Patient. Philadelphia, PA:Elsevier Mosby. 2005:583-595.
Munday S, Wallace KL. Flumazenil. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW,
eds. Critical Care Toxicology – Diagnosis and Management of the Critically Poisoned Patient.
Philadelphia, PA:Elsevier Mosby. 2005:1493-1497.
Wallace KL. Pentachlorophenol. In: Hoffman HE, Palmer RB, Phillips S, eds. Clinical Practice of
Biological Monitoring. Beverly Farms, MA:OEM Press. 2012:166-169.
Journal Articles
Glass D, Litvin D, Wallace KL, et al: Early-onset particular JRA associated with HLA-DRw5, iritis, and
ANA. J Clin Invest 1980; 66:426-429.
Wallace KL, Slovis CM: Hepatic vein bullet embolus as a complication of left thoracic gunshot injury.
Ann Emerg Med 1987; 16(1):102-104.
Wallace KL, Slovis CM: Altered mental status. Case Studies in Emergency Medicine 1987; 3(6):9-11.
Wallace KL: Prehospital quality assurance: focus on product evaluation. J Maine EMS 1990; 1(1):14-15.
Wallace KL: New airway management devices. J Maine EMS 1990; 1(2):14-19.
Wallace KL: Prehospital esophageal airways: another role for endtidal CO2 detection? J Maine EMS
1991; 2(2):17-18.
Clark D, Zeiger M, Wallace KL, et al: Blunt aortic trauma: signs of high risk. J Trauma 1990;
30(6):701-705.
Higgins GL, Campbell B, Wallace KL, Talbot S: Pediatric poisoning from over-the-counter imidazoline-
containing products. Ann Emerg Med 1993; 20(6):655-658.
Higgins GL, Lambrew C, Hunt E, Wallace KL, et al: Expediting the early hospital care of the adult
patient with nontraumatic chest pain: impact of a modified ED triage protocol. Am J Emerg Med 1993;
11(6):576-582.
Wallace KL: Antibiotic-induced convulsions. Crit Care Clin N Am 1997; 13(4): 741-761.
Wallace KL, Morkunas AR: Commonly abused prescription sedative hypnotic drugs. Topics Emerg
Med 1997; 19(4):26-37.
Wallace KL, Curry SC, LoVecchio F, Raschke RA: Effect of magnesium hydroxide on iron absorption
following simulated mild iron overdose in human subjects. Acad Emerg Med 1998; 5(10):961-965.
6
Kevin L. Wallace, MD, FACMT
Suchard JR, Wallace KL, Gerkin RD: Acute cyanide toxicity caused by apricot kernel ingestion. Ann
Emerg Med 1998; 32(6):742-4.
Wallace KL, Suchard J, Curry SC, Reagan C: Diagnostic Use of Physicians' Detection of Urine
Fluorescence in a Simulated Ingestion of Sodium Fluorescein-Containing Antifreeze. Ann Emerg Med
2001; 38(1):49-54.
LoVecchio FL, Curry SC, Graeme KA, Wallace KL, Suchard J: Intravenous pyridoxine-induced
metabolic acidosis. Ann Emerg Med 2001; 38(1):62-64.
Brent J, McMartin K, Phillips S, Burkhart KK, Donovan JW, Wells M, Kulig K, Bogdan G, Dart R,
Heard K, Kokan L, Akhtar J, Ahsan N, Zimmerman H, Curry S, Wallace K, et al. Fomepizole for the
treatment of ethylene glycol poisoning. N Eng J Med 1999;340;832-8.
Wallace KL, Curry SC: Post-collection rise in methemoglobin level in frozen blood specimens. J
Toxicol Clin Toxicol 2002; 40(1):91-94.
Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DB, Graeme KA, Wallace KL, et al. Initial
postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake
envenomation. Ann Emerg Med 2002; 39(6):609-615.
Brooks DE, Wallace KL. Acute propylene glycol ingestion. J Toxicol Clin Toxicol 2002;40(4):513-516.
LoVecchio F, Cannon RD, Algier J, Ruha A, Curry SC, Wallace KL, Graeme KA. Bee swarmings in
children. Am J Emerg Med 2007;25:931-933.
Charlton N, Wallace KL. American College of Medical Toxicology Position Statement on Post-Chelator
Challenge Urinary Metal Testing. J Med Toxicol 2010;6:74-75.
McCall KL, Tu C, Lacroix M, Holt C, Wallace KL, Balk J. Controlled substance prescribing trends and
physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription
Monitoring Program from 2006 to 2010. Journal of Substance Use 2012 (doi: 10.3109/14659891.2012.
685794)
Murphy CM. (Leikin J, Brent J, Wallace K, Beuhler M, Raymond L). Fear not the IME. J Med Toxicol
2012;8:3-4.
Letters to the Editor
Suchard J, Wallace KL, et al: Cutaneous nodular reaction to oral mercury. J Am Acad Dermatol 1998;
38(5:1):784-785.
Wallace KL, Graeme KA, Morkunas A, Curry SC: Zolpidem binds to w, not m, receptors. J Toxicol
Clin Toxicol 1998; 36(1&2):143-144.
Wallace KL, Curry SC, LoVecchio F, Raschke RA: Effect of magnesium hydroxide on iron absorption
after ferrous sulfate. Ann Emerg Med 1999; 34(5):685-686.
7
Kevin L. Wallace, MD, FACMT
Wallace KL, Kunkel DB: Legal hemp products and urine cannabinoid testing. J Toxicol Clin Toxicol
1999; 37(7):897-898.
Wallace KL, Suchard J: Food pollution. Otolaryngol Head Neck Surg 2000; 122(3):466-467.
Ruha A, Wallace KL, Tanen DA, Patel P: Dilute diquat death. Am J Emerg Med 2001; 19(6):527-528.
LoVecchio F, Pizon AF, Wallace KL, Kunkel DB. Myokymia following snake envenomation in Arizona.
Wilderness Environ Med 2005; 16:116-117
Charlton NP, Lawrence DT, Wallace KL. Falsely elevated salicylate levels. J Med Toxicol 2008;
4(4):310-311.
Abstracts
Wallace KL, Slovis CM: Case presentation: the patient with altered mental status. Abstract. South Med
J 1986; 79:9 (Suppl. #2):15
Naylor JK, Riker RR, Wallace KL: Critical care Toxicology: ICU vs non-ICU admission, substance type,
and therapeutic interventions. Am J Respir Crit Care Med 1995; 151: A491.
Wallace KL, Gerkin R, Mitchell R: Acute cyanide toxicity due to apricot kernel ingestion. J Toxicol Clin
Toxicol 1996; 34(5):599.
Wallace KL, LoVecchio F, Kunkel DB, Carlton MW: Myokymia following snake envenomation in
Arizona. J Toxicol Clin Toxicol 1997; 35(5):531-532.
Wallace KL, Curry SC, Graeme K: Effectiveness of flumazenil in the reversal of baclofen-induced CNS
depression in rats. J Toxicol Clin Toxicol 1997; 35(5):548.
Wallace KL, Curry SC, LoVecchio FL, Raschke RA: Effect of magnesium oxide on iron absorption
following simulated iron overdose in human beings: a randomized controlled trial. J Toxicol Clin
Toxicol 1997; 35(5):563-564.
Graeme KA, Wallace KL, Curry SC, Tanen DA, Higgins TJ: Hydrogen sulfide-induced changes in coin
appearance. J Toxicol Clin Toxicol 1998; 36(5):469.
LoVecchio F, Curry SC, Wallace KL, Graeme KA, Suchard JR: Pyridoxine hydrochloride infusion effect
on acid-base status. J Toxicol Clin Toxicol 1998; 36(5): 428.
Wallace KL, Suchard J, Curry SC, Reagan C: Accuracy and reliability of urine fluorescence by Wood's
lamp examination for antifreeze ingestion. J Toxicol ClinToxicol 1999; 37(5):669.
Wallace KL, Curry SC, Brooks D: Post-collection rise in methemoglobin level in frozen blood. J
Toxicol Clin Toxicol 2000; 38(5):522.
Wallace KL, Gerkin R, Gatewood P: Demonstration of clobenzorex exposure as an explanation for
GC/MS-confirmed positive urine tests specific for amphetamine. J Toxicol Clin Toxicol 2000;
38(5):540-541.
8
Kevin L. Wallace, MD, FACMT
Brooks DE, Wallace KL, Katz K: Acute propylene glycol ingestion. J Toxicol Clin Toxicol 2001;
39(5):482.
Ruha AM, Beuhler M, Brooks D, Wallace KL et al: CroFab for treatment of rattlesnake envenomation. J
Toxicol Clin Toxicol 2001; 39(5):546.
Oehme FW, Coppock RW, Wallace KL, Peterson ME, et al. Toxicology of naturally occurring toxins.
Toxicol Sci 2002; 66(1-S):2.
Brooks D, Wallace KL, Wax P, Watts D, Holubek W: Misleading liver needle biopsy in transplant
evaluation for acetaminophen-induced fulminant liver failure. J Toxicol Clin Toxicol 2002; 40(5):606.
LoVecchio F, Klemens J, Curry SC, Wallace KL. Validation of a metformin poison center Protocol: a
48-month experience in toddlers. J Toxicol Clin Toxicol 2003; 41(5):683.
Beuhler MC, Wallace KL. Benign outcome with toxic serum iron levels following IV iron dextran
overdose in three patients. J Toxicol Clin Toxicol 2003; 41(5):738-739.
LoVecchio F, Watts D, Curry SC, Wallace KL. Acute renal failure, neuropathy, and myopathy after
ingestion of dipropylene glycol-containing Fantasiaä fog solution. J Toxicol Clin Toxicol 2003;
41(5):647.
LoVecchio F, Pizon AF, Wallace KL, Kunkel DB. Myokymia following snake envenomation in Arizona.
Wilderness Environ Med 2005; 16:116-117.
Cannon R, Wallace K. Rapid clinical improvement after carnitine administration in valproate-induced
hyperammonemic encephalopathy (VHE). Clin Toxicol 2007;45(6):625.
Riley BD, Quan D, Wallace KL. Early MRI findings do not appear predictive of outcome in severe
ethylene glycol-induced brain injury. Clin Toxicol 2007;45(6):628.
Gresham C, Wallace KL. Challenges in detection and confirmation of modafinil use. Clin Toxicol
2008;46(7):642.
Other Publications
Platinum. In: The Third National Report on Human Exposure to Environmental Chemicals. National
Center for environmental Health, DHHS, Washington, D.C. 2005:56-58.
Thallium. In: The Third National Report on Human Exposure to Environmental Chemicals. National
Center for environmental Health, DHHS, Washington, D.C. 2005:59-61.
Wallace KL. Recognizing and reducing risks of narcotic analgesic harm. Blue Ridge Poison Center Tox
Talks. November 2008. Available@: http://www.healthsystem.virginia.edu/internet/medtox/education/
toxtalks/Nov08NarcoticAnalgesics.pdf.
Wallace KL. Health effects of indoor exposure to mold and mold toxins. Blue Ridge Poison Center Tox
Talks. May 2009. Available @: http://www.healthsystem.virginia.edu/internet/medtox /education/
toxtalks/May09-Mold.pdf.
9
Kevin L. Wallace, MD, FACMT
Presentations
Community Educational Presentations
Environmental Illness/MCS. Jones, Skelton & Hochuli Insurance Law Seminar, Phoenix, AZ (May 1997)
Legal Aspects of Blood Alcohol. Industrial Commission of Arizona Annual Seminar, Mesa, AZ (August
1997)
Hydrofluoric Acid. Environmental Health and Safety Summit Conference. ON Semiconductor, Phoenix,
AZ (October 2000)
Toxic Gases of the Semiconductor Industry. Environmental Health and Safety Summit Conference. ON
Semiconductor, Phoenix, AZ (October 2000)
Biological Monitoring of Mercury Exposure. State of New Hampshire Office of Community and Public
Health, Bureau of Health Risk Assessment, Concord, NH (October 2001)
Health Effects of Indoor Mold Contamination. State of Arizona Risk Management, Phoenix, AZ
(February 2002)
Health Effects of Indoor Mold Contamination. 2002 Annual Update of Arizona Law, Phoenix, AZ (May
2002)
Chemical Irritant Inhalational Injury. Industrial Commission of Arizona Annual Seminar Phoenix, AZ
(August 2002)
Mold Mania. Certified Hazardous Materials Managers Meeting. Phoenix, AZ (March 2004)
Acute Chemical Irritant-induced Respiratory Tract Injury. Rehabilitation Insurance Nurses Group,
Monthly Meeting. Phoenix, AZ (January 2006)
Health Effects of Indoor Mold Exposure. Northern New England Defense Counsel Association.
Woodstock, VT (March 2006)
Acute Airborne Chemical Irritant Injury. Workers Compensation Claims Division. St. Paul Travelers.
Phoenix, AZ (June 2006)
Health Effects of Indoor Mold Exposure. True North Health Center. Falmouth, ME (June 2006)
Medical Toxicology: Background, Scope of Practice, and Guiding Principles. American Association of
Legal Nurse Consultants. Phoenix, AZ (November 2006)
Approach to Workplace Toxic Exposure Claim. Arizona Workers Compensation Claims Association
Seminar. Phoenix, AZ (February 2007)
Environmental Risk Factors for Cancer. 2007 Living with Cancer Conference. American Cancer
Society. Augusta, ME (May 2007)
10
Kevin L. Wallace, MD, FACMT
Perilous Polypharmacy. Medical Staff CME Meeting. Rockingham Memorial Hospital, Harrisonburg,
VA (June 2009)
Partnering in Medication Safety. Presentation to the Elderly. Cape Elizabeth Community Services, Cape
Elizabeth, ME (September 2009)
Partnering in Medication Safety. Presentation to the Elderly. Sunnyside Village Retirement Community,
Sarasota, FL (October 2009)
OccTox Exposure Claims, Arizona Workers Comp Claims Adjustors Association, Monthly Dinner
Meeting Presentation, Phoenix, AZ (November 2009)
Partnering in Medication Safety, Presentation to Mental Health Support Group, Family Involvement
Center, Phoenix, AZ (November 2009)
Perilous Polypharmacy - Partnering in Medication Safety. St. George's Episcopal Church, Sanford, ME
(October 2012)
Medical Professional Presentations
Pediatric Pain Management. Emergency Medicine Update, Colby College, Waterville, ME (July 1988)
Diabetic Ketoacidosis. Annual Conference on Acute Medical Problems for the Primary Care Physician
Assistants, Portland, ME (September 1989)
EMS Controversies. Emergency Medicine Winter Symposium, Sugarloaf, Waterville, ME (March 1991)
EMS Controversies. Emergency Medicine Update, Colby College, Waterville, ME (July 1991)
Carbon Monoxide Poisoning. Annual Conference on Acute Medical Problems for the Primary Care
Physician Assistants, Portland, ME (September 1991)
Lightning Injuries. Emergency Medicine Update, Colby College, Waterville, ME (July 1992)
Electrical and Lightning Injuries. Annual Conference on Acute Medical Problems for the Primary Care
Physician Assistants, Portland, ME (September 1992)
Electrical and Lightning Injuries. Grand Rounds, Dept. of Emergency Medicine, Maine Medical Center,
Portland, ME (September 1992)
Drugs of Abuse. Emergency Medicine Winter Symposium, Sugarloaf, ME ( February 1993)
Street Drugs. Emergency Medicine Update, Colby College, Waterville, ME (August 1993)
Prescription Drug Seeking. Annual Conference on Acute Medical Problems for the Primary Care
Physician Assistants, Portland, ME (September 1993)
Living with Prozac Overdose. Medical Update Conference, Dept. of Psychiatry, Maine Medical Center,
Portland, ME (December 1993)
11
Kevin L. Wallace, MD, FACMT
Street Drugs. Annual Conference on Acute Medical Problems for the Primary Care Physician Assistants,
Portland, ME (October 1994)
Opioid Abuse/Dependence. Medical Update Conference, Dept. of Psychiatry, Maine Medical Center,
Portland, ME (November 1994)
Street Drug Management Controversies. Emergency Medicine Winter Symposium, Sugarloaf,
Waterville, ME (March, 1995)
Clinical Pharmacology & Toxicology Review. Mayo Clinic Internal Medicine Board Review, Scottsdale,
AZ (August 1997)
Controversies in Pediatric Toxicology. Pediatric Grand Rounds. St. Joseph’s Children’s Health Center,
Phoenix, AZ (December 1997)
Common Southwestern Arthropod Envenomations. Continuing Education Series. Huhukam Memorial
Hospital, Gila River Healthcare, Sacaton, AZ (November 1998)
Rattlesnake Envenomation. Continuing Education Series. Huhukam Memorial Hospital, Sacaton, AZ
(March 1999)
Clinical Pharmacology and Toxicology Review. Mayo Clinic Internal Medicine Board Review.
Scottsdale, AZ (August 2000)
The Clinical Toxicology of Neurotransmitters - Nicotinic Neurotransmission (coordinator/moderator).
AACT Symposium. North American Congress of Clinical Toxicology, Tucson, AZ (September 2000)
Mercury Vapor Exposure. Division of Laboratory Sciences, National Center for Environmental Health,
Center for Disease Control, Atlanta, GA (December 2000)
Hydrofluoric Acid Exposure. Dartmouth Hitchcock Medical Center/New Hampshire Poison Information
Center. Lebanon, NH (May 2001)
Rattlesnakes and Gila Monsters: Introduction to Clinical Envenomation. Society of Toxicology 41st
Annual Meeting, Nashville, TN (March 2002)
Sick Building Syndrome/Toxic Mold Menace. Banner Occupational Health Services, Phoenix, AZ (June
2002)
Phantom Risks: How Can We Distinguish Health Scares From True Hazards? New England Regional
Toxicology Conference, Sturbridge, MA (September 2002)
Antihistamines. Department of Pediatrics, Phoenix Children’s Hospital. Phoenix, AZ (March 2003)
Acute Airborne Chemical Irritant Injury. New England Regional Toxicology Conference. Storrs, CT
(September 2003)
Acute Alkyl Mercury Poisoning. New England Regional Toxicology Conference. Storrs, CT (Sept ember
2003)
12
Kevin L. Wallace, MD, FACMT
Chemical Terrorism: Unconventional Use of Conventional Chemicals. Medicine Grand Rounds.
Dartmouth-Hitchcock Medical Center, Lebanon, NH (February 2004)
Fungal Exposure & Health: Toxic versus Allergic Effects. Allergic Dilemmas in Primary Practice.
Hackensack University Medical Center. Hackensack, NJ (April 2004)
Environmental Emergencies: Chemical Terrorism. Grand Rounds. Department of Emergency Medicine,
Maine Medical Center, Portland, ME (April 2005)
Mold Mania. New Hampshire Association of Occupational Nurses Meeting. Manchester, NH (October
2005).
Non-Conventional Potential Agents of Attack. Chemical Agents of Opportunity: TICS and TIMS.
Maine Medical Center, Portland, ME (December 2005)
The Numbing Diversity of Toxic Peripheral Neuropathy. American College of Medical Toxicology
Spring Course. Phoenix, AZ (March 2006)
Terrorism by Fear and Uncertainty. Chemical Agents of Opportunity: TICS and TIMS. Dartmouth-
Hitchcock Medical Center, Lebanon, NH (April 2006)
Assessing and Addressing Hazards and Vulnerabilities. Chemical Agents of Opportunity: TICS and
TIMS. Rhode Island Hospital, Providence, NH (May 2006)
Toxic Peripheral Neuropathy. Harvard Medical Toxicology Fellowship, Children’s Hospital Boston.
Boston, MA (January 2007)
Toxicology of Methadone and Other Opioids. Grand Rounds. Department of Emergency Medicine,
Maine Medical Center, Portland, ME (February 2007)
Forensic Alcohol Test Interpretation. Harvard Medical Toxicology Fellowship, Children’s Hospital
Boston. Boston, MA (April 2007)
Salicylate Poisoning. Grand Rounds. Department of Emergency Medicine, Maine Medical Center,
Portland, ME (August 2007)
Post-Incident Medical Surveillance. Harvard Medical Toxicology Fellowship, Children’s Hospita l
Boston. Boston, MA (August 2007)
Medical Toxicology in the Workplace. Noon Conference. Department of Physical Medicine &
Rehabilitation, University of Virginia Health System. Charlottesville, VA (January 2009)
Toxicological Detection of Substance Abuse in the Emergency Care Setting. Second International
Addiction Medicine Symposium. Universidad de Ciencias Medicas, San Jose, Costa Rica (March 2009)
Nanotoxicology Symposium. Coordinator/Speaker (“Clinical Perspective”). University of Virginia
Division of Medical Toxicology. Charlottesville, VA (May 2009)
13
Kevin L. Wallace, MD, FACMT
Perilous Polypharmacy. Interprofessional Educational Seminar. University of New England College of
Pharmacy. Portland, ME (October 2009)
Perilous Polypharmacy II. University of New England College of Pharmacy. Portland, ME (November
2009)
Perilous Polypharmacy. Harvard Medical Toxicology Fellowship, Children’s Hospital Boston. Boston,
MA (November 2009)
Perilous Polypharmacy - Partnering in Medication Safety. 99th Annual Convention. Maine Osteopathic
Association. Rockport, ME (June 2010)
Polypharmacy. Patient Safety Academy. University of Southern Maine, Portland, ME (August 2010)
Perilous Polypharmacy- Partnering in Medication Safety. 2010 International Symposium on Safe
Medicine. Portland, ME (October 2010)
Perilous Polypharmacy. 5th Annual Psychiatry Update. Maine Association of Psychiatric Physicians.
Portland, ME (April 2011)
Perilous Polypharmacy – Partnering in Medication Safety. CE & SNOW 2012. Maine Society of Health-
System Pharmacists Annual Conference. Sunday River Resort. Bethel, ME (January 2012)
Perilous Polypharmacy - Partnering in Medication Safety. 22nd Annual Maine Geriatrics Conference. Bar
Harbor, ME (June 2012)
Scholarly Platform Presentations
Wallace KL, Curry SC, LoVecchio FL, Raschke RA: Effect of magnesium oxide on iron absorption
following simulated iron overdose in human beings: a randomized controlled trial. North American
Congress of Clinical Toxicology, St. Louis, MI (September 1997)
Wallace KL, Suchard J, Curry SC, Reagan C: Accuracy and reliability of urine fluorescence by Wood's
lamp examination for antifreeze ingestion. North American Congress of Clinical Toxicology, La Jolla,
CA (October 1999)
Scholarly Poster Presentations
Wallace KL, Gerkin R, Mitchell R: Acute cyanide toxicity due to apricot kernel ingestion. North
American Congress of Clinical Toxicology, Portland,OR (October 1996)
Wallace KL, LoVecchio F, Kunkel DB, Carlton MW: Myokymia following snake envenomation in
Arizona. North American Congress of Clinical Toxicology, St. Louis, MI (September 1997)
Wallace KL, Curry SC, Graeme K: Effectiveness of flumazenil in the reversal of baclofen-induced CNS
depression in rats. North American Congress of Clinical Toxicology, St. Louis, MI (September 1997)
14
Kevin L. Wallace, MD, FACMT
Skolfield S, Lambert D, Tomassoni A, Wallace KL: Inadequate regional antidote and medication
supplies for poisoning emergencies. North American Congress of Clinical Toxicology, St. Louis, MI
(Sept. 1997)
Graeme KA, Wallace KL, Curry SC, Tanen DA, Higgins TJ: Hydrogen sulfide-induced changes in coin
appearance. North American Congress of Clinical Toxicology, Orlando, FL (September 1998)
LoVecchio F, Curry SC, Wallace KL, Graeme KA, Suchard JR: Pyridoxine \hydrochloride infusion
effect on acid-base status. North American Congress of Clinical Toxicology, Orlando, FL (September
1998)
Wallace KL, Curry SC, Brooks D: Post-collection rise in methemoglobin level in frozen blood. North
American Congress of Clinical Toxicology, Tucson, AZ (September 2000)
Wallace KL, Gerkin R, Gatewood P: Demonstration of clobenzorex exposure as an explanation for
GC/MS-confirmed positive urine tests specific for amphetamine. North American Congress of Clinical
Toxicology, Tucson, AZ (September 2000)
Brooks DE, Wallace KL, Katz K: Acute propylene glycol ingestion. North American Congress of
Clinical Toxicology, Montreal, Quebec (October 2001)
Ruha AM, Beuhler M, Brooks D, Wallace KL et al: CroFab for treatment of rattlesnake envenomation.
North American Congress of Clinical Toxicology, Montreal, Quebec (October 2001)
Brooks D, Wallace KL, Wax P, Watts D, Holubek W: Misleading liver needle biopsy in transplant
evaluation for acetaminophen-induced fulminant liver failure. North American Congress of Clinical
Toxicology, Palm Springs, CA (September 2002)
Health Effects of Indoor Mold Exposure. Payson Regional Medical Center, Payson, AZ (October 2002)
LoVecchio F, Klemens J, Curry SC, Wallace KL. Validation of a metformin poison center Protocol: a
48-month experience in toddlers. North American Congress of Clinical Toxicology, Chicago, IL
(September 2003)
Beuhler MC, Wallace KL. Benign outcome with toxic serum iron levels following IV iron Dextran
overdose in three patients. North American Congress of Clinical Toxicology, Chicago, IL (September
2003)
LoVecchio F, Watts D, Curry SC, Wallace KL. Acute renal failure, neuropathy, and Myopathy after
ingestion of dipropylene glycol-containing Fantasiaä fog solution. North American Congress of Clinical
Toxicology, Chicago, IL (September 2003)
Cannon R, Wallace K. Rapid clinical improvement after carnitine administration in valproate-induced
hyperammonemic encephalopathy (VHE). North American Congress of Clinical Toxicology, New
Orleans, LA (October 2007)
Riley BD, Quan D, Wallace KL. Early MRI findings do not appear predictive of outcome in severe
ethylene glycol-induced brain injury. North American Congress of Clinical Toxicology, New Orleans, LA
(October 2007)
15
Kevin L. Wallace, MD, FACMT
Gresham C,Wallace KL. Challenges in detection and confirmation of modafinil use. North American
Congress of Clinical Toxicology, Toronto, ON (September 2008)
Balk J, Holt C, Wallace K, Tu C, Lacroix M, McCall K. Controlled substance prescribing trends and
physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription
Monitoring Program, 2006-2010. North American Primary Care Research Group Annual Meeting, Banff,
Alberta, Canada (November 2011)
Recorded Audiovideo Presentations
Wallace KL. Introduction to Toxic Risk Assessment. New England Consortium of Poison Control
Centers: Addressing Concerns Regarding Low-Intensity Environmental Exposures. (March 2004).
Wallace KL. Principles of Risk Assessment. New England Consortium of Poison Control Centers:
Addressing Concerns Regarding Low-Intensity Environmental Exposures. (June 2004).
Grant Support
1995 Orphan Medical Corporation (corporate multicenter trial sponsor)
1996 Palms Hospital Clinic Foundation (private foundation)
1998 Palms Hospital Clinic Foundation (private foundation)
2003-2004 Poison Control Ctr. Stabilization & Enhancement Grant (HRSA CFDA #93.253)
2005-2006 Environmental Health Sciences Center at Dartmouth (institutional pilot grant)
ACMT/ATSDR – Chemical Agents of Opportunity
2006 (cooperative educational grant)
Virginia Department of Health – Lead Prevention
2008 (cooperative educational grant)
16